{"transactions":[{"id":732427,"issuer":{"id":5996,"kind":"organization","name":"Sionna Therapeutics, Inc.","symbol":"SION"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-18T21:48:01.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":17340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full upon the earlier of June 17, 2027 or the date of the next annual meeting of Sionna Therapeutics, Inc., subject to the Reporting Person's continued service on such vesting date."}],"balance_after":17340,"derivative":{"exercise_price":36.73,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":17340},"source":{"system":"sec-edgar","filing":"0001816744-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2036042/000181674426000002/edgardoc.xml","form_type":"4"}},{"id":1110097,"issuer":{"id":5996,"kind":"organization","name":"Sionna Therapeutics, Inc.","symbol":"SION"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-16T21:08:46.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":19959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full upon the earlier of June 12, 2026 or the date of the next annual meeting of Sionna Therapeutics, Inc., subject to the Reporting Person's continued service on such vesting date."}],"balance_after":19959,"derivative":{"exercise_price":16.99,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":19959},"source":{"system":"sec-edgar","filing":"0002036042-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2036042/000203604225000034/edgardoc.xml","form_type":"4"}},{"id":1276908,"issuer":{"id":5996,"kind":"organization","name":"Sionna Therapeutics, Inc.","symbol":"SION"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-10T21:05:12.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":39919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in three equal annual installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":39919,"derivative":{"exercise_price":18,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":39919},"source":{"system":"sec-edgar","filing":"0000950170-25-017036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2036042/000095017025017036/ownership.xml","form_type":"4"}},{"id":1824913,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-21T21:13:33.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest in full on the earlier of (i) the one-year anniversary of the grant date or on (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.72,"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-043145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919123043145/doc4.xml","form_type":"4"}},{"id":1928651,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T21:07:41.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":21028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon the settlement of restricted stock units (\"RSUs\").  The fully vested RSUs were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $14,375."}],"balance_after":21028,"source":{"system":"sec-edgar","filing":"0001209191-23-022808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919123022808/doc4.xml","form_type":"4"}},{"id":2222148,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-24T22:50:51.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":37500,"price":1.4,"value":52500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $52,500 (\"Election Option\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $52,500 (\"Election Option\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-half of the Election Option vested and became exercisable on June 22, 2022, and 25% of each Election Option will vest and become exercisable on each of September 30, 2022 and December 31, 2022, subject to the continuous service of the Reporting Person with the Issuer on each vesting date."}],"balance_after":37500,"derivative":{"exercise_price":2.01,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-22-039329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919122039329/doc4.xml","form_type":"4"}},{"id":2222147,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-24T22:50:51.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":10167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date."}],"balance_after":10167,"derivative":{"exercise_price":2.01,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":10167},"source":{"system":"sec-edgar","filing":"0001209191-22-039329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919122039329/doc4.xml","form_type":"4"}},{"id":2224267,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-22T21:40:21.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest in full on the earlier of (i) the one-year anniversary of the grant date or on (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.54,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-038736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919122038736/doc4.xml","form_type":"4"}},{"id":2231569,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-15T21:02:45.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":44843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in twelve equal monthly installments beginning on July 13, 2022, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":44843,"derivative":{"exercise_price":2.79,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":44843},"source":{"system":"sec-edgar","filing":"0000899243-22-022614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924322022614/doc4.xml","form_type":"4"}},{"id":2712566,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-05-15T00:09:34.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":2571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error related to the calculation date of the Black-Scholes value."},{"field":"shares","element":"transactionShares","label":"F4","text":"The number of shares underlying the option was erroneously reported as 2,653 on the original Form 4 filed on May 7, 2021 due to an administrative error related to the calculation date of the Black-Scholes value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"50% of the shares subject to the option are fully vested and exercisable, and 25% will vest and become exercisable on September 30, 2021 and December 31, 2021, subject to the continuous service of the Reporting Person on each vesting date."}],"balance_after":2571,"derivative":{"exercise_price":23.2,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":2571},"source":{"system":"sec-edgar","filing":"0001209191-21-032974","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919121032974/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-07"}},{"id":2712565,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-05-15T00:09:34.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":10167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will fully vest and become exercisable on May 3, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date. The original Form 4 filed on May 7, 2021 erroneously reported this vesting date as May 4, 2022."}],"balance_after":10167,"derivative":{"exercise_price":23.2,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":10167},"source":{"system":"sec-edgar","filing":"0001209191-21-032974","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919121032974/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-07"}},{"id":2712564,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-14T21:17:04.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":23419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3rd) of the shares subject to the option vest on May 12, 2022, and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":23419,"derivative":{"exercise_price":12.27,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":23419},"source":{"system":"sec-edgar","filing":"0001209191-21-032819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919121032819/doc4.xml","form_type":"4"}},{"id":2723403,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-05-08T01:59:01.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":2653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the shares subject to the option are fully vested and exercisable, and 25% will vest and become exercisable on September 30, 2021 and December 31, 2021, subject to the continuous service of the Reporting Person on each vesting date."}],"balance_after":2653,"derivative":{"exercise_price":22.5,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":2653},"source":{"system":"sec-edgar","filing":"0001209191-21-031110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919121031110/doc4.xml","form_type":"4"}},{"id":2723402,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-05-08T01:59:01.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":10167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will fully vest and become exercisable on May 4, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date."}],"balance_after":10167,"derivative":{"exercise_price":22.5,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":10167},"source":{"system":"sec-edgar","filing":"0001209191-21-031110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919121031110/doc4.xml","form_type":"4"}},{"id":2764547,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-04-01T23:59:21.000Z","date":"2021-04-01","kind":"disposition_to_issuer","acquired":false,"shares":73789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to the Merger Agreement in exchange for the excess of the Offer Price over the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All options were vested and exercisable as of immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":17.75,"expiration_date":"2031-02-07","underlying":"Common Stock","underlying_shares":73789},"source":{"system":"sec-edgar","filing":"0000899243-21-014467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924321014467/doc4.xml","form_type":"4"}},{"id":2764546,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-04-01T23:59:21.000Z","date":"2021-04-01","kind":"disposition_to_issuer","acquired":false,"shares":114876,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to the Merger Agreement in exchange for the excess of the Offer Price over the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All options were vested and exercisable as of immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":18,"expiration_date":"2030-07-16","underlying":"Common Stock","underlying_shares":114876},"source":{"system":"sec-edgar","filing":"0000899243-21-014467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924321014467/doc4.xml","form_type":"4"}},{"id":2764545,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-01T23:59:21.000Z","date":"2021-04-01","kind":"other","acquired":false,"shares":1200,"price":60,"value":72000.0,"ownership":{"direct":false,"nature":"By husband"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated February 24, 2021, among Pandion Therapeutics, Inc. (the \"Company\"), Merck Sharp & Dohme Corp. (\"Merck\") and Panama Merger Sub, Inc. (\"Merger Sub\"), Merger Sub commenced a tender offer (the \"Offer\") to purchase all outstanding Company common stock for the price of $60.00 per share in cash (the \"Offer Price\"). On April 1, 2021, the Offer consummated, after which Merger Sub merged with and into the Company (the \"Merger\") and the Company became a wholly owned subsidiary of Merck. At the consummation of the Offer and the Merger, respectively, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Offer Price and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were cancelled and converted automatically into the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-014467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924321014467/doc4.xml","form_type":"4"}},{"id":2764544,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-01T23:59:21.000Z","date":"2021-04-01","kind":"other","acquired":false,"shares":503254,"price":60,"value":30195240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated February 24, 2021, among Pandion Therapeutics, Inc. (the \"Company\"), Merck Sharp & Dohme Corp. (\"Merck\") and Panama Merger Sub, Inc. (\"Merger Sub\"), Merger Sub commenced a tender offer (the \"Offer\") to purchase all outstanding Company common stock for the price of $60.00 per share in cash (the \"Offer Price\"). On April 1, 2021, the Offer consummated, after which Merger Sub merged with and into the Company (the \"Merger\") and the Company became a wholly owned subsidiary of Merck. At the consummation of the Offer and the Merger, respectively, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Offer Price and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were cancelled and converted automatically into the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-014467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924321014467/doc4.xml","form_type":"4"}},{"id":2869561,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-10T21:45:34.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":73789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on February 8, 2021. 1/4 of the shares underlying the award shall vest on February 8, 2022, with the remainder of the shares vesting in equal monthly installments following February 8, 2022 through February 8, 2025, subject to the reporting person's continued service on each applicable vesting date."}],"balance_after":73789,"derivative":{"exercise_price":17.75,"expiration_date":"2031-02-07","underlying":"Common Stock","underlying_shares":73789},"source":{"system":"sec-edgar","filing":"0000899243-21-005684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924321005684/doc4.xml","form_type":"4"}},{"id":3078958,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series B Preferred Stock","published_at":"2020-07-21T23:32:06.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":107768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21133},"source":{"system":"sec-edgar","filing":"0000899243-20-019860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924320019860/doc4.xml","form_type":"4"}},{"id":3078957,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-21T23:32:06.000Z","date":"2020-07-17","kind":"grant","acquired":true,"shares":58239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on June 25, 2021, with the remainder of the shares vesting in equal monthly installments following June 25, 2021 through June 25, 2024, subject to the reporting person's continued service on each applicable vesting date."}],"balance_after":58239,"derivative":{"exercise_price":18,"expiration_date":"2030-07-16","underlying":"Common Stock","underlying_shares":58239},"source":{"system":"sec-edgar","filing":"0000899243-20-019860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924320019860/doc4.xml","form_type":"4"}},{"id":3078956,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-21T23:32:06.000Z","date":"2020-07-17","kind":"grant","acquired":true,"shares":56637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on May 21, 2021, with the remainder of the shares vesting in equal monthly installments following May 21, 2021 through May 21, 2024, subject to the reporting person's continued service on each applicable vesting date."}],"balance_after":56637,"derivative":{"exercise_price":18,"expiration_date":"2030-07-16","underlying":"Common Stock","underlying_shares":56637},"source":{"system":"sec-edgar","filing":"0000899243-20-019860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924320019860/doc4.xml","form_type":"4"}},{"id":3078955,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-07-21T23:32:06.000Z","date":"2020-07-21","kind":"purchase","acquired":true,"shares":1200,"price":18,"value":21600.0,"ownership":{"direct":false,"nature":"By husband"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares purchased through a directed share program in connection with the initial public offering of Pandion Therapeutics, Inc.'s common stock, which closed on July 21, 2020. These shares of common stock were purchased at the public offering price of $18.00 per share."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0000899243-20-019860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924320019860/doc4.xml","form_type":"4"}},{"id":3078954,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-07-21T23:32:06.000Z","date":"2020-07-21","kind":"exercise","acquired":true,"shares":21133,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":503254,"source":{"system":"sec-edgar","filing":"0000899243-20-019860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000089924320019860/doc4.xml","form_type":"4"}},{"id":3092481,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":36886,"kind":"person","name":"Viney Joanne L.","position":1,"cik":"0001816744","reported_name":"Viney Joanne L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-07-02T22:49:15.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":20335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in three equal annual installments measured from the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":20335,"derivative":{"exercise_price":17.49,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":20335},"source":{"system":"sec-edgar","filing":"0001209191-20-040669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816744/000120919120040669/doc4.xml","form_type":"4"}}]}